www.fdanews.com/articles/152717-active-biotech-ab-releases-results-from-phase-ii-iii-anyara-trial-for-the-treatment-of-renal-cell-cancer

Active Biotech AB Releases Results From Phase II/III ANYARA Trial for the Treatment of Renal Cell Cancer

January 28, 2013

Active Biotech announced the initial results from the ANYARA Phase II/III clinical study.
4-Traders